Literature DB >> 21209217

IκB kinase regulates social defeat stress-induced synaptic and behavioral plasticity.

Daniel J Christoffel1, Sam A Golden, Dani Dumitriu, Alfred J Robison, William G Janssen, H Francisca Ahn, Vaishnav Krishnan, Cindy M Reyes, Ming-Hu Han, Jessica L Ables, Amelia J Eisch, David M Dietz, Deveroux Ferguson, Rachael L Neve, Paul Greengard, Yong Kim, John H Morrison, Scott J Russo.   

Abstract

The neurobiological underpinnings of mood and anxiety disorders have been linked to the nucleus accumbens (NAc), a region important in processing the rewarding and emotional salience of stimuli. Using chronic social defeat stress, an animal model of mood and anxiety disorders, we investigated whether alterations in synaptic plasticity are responsible for the long-lasting behavioral symptoms induced by this form of stress. We hypothesized that chronic social defeat stress alters synaptic strength or connectivity of medium spiny neurons (MSNs) in the NAc to induce social avoidance. To test this, we analyzed the synaptic profile of MSNs via confocal imaging of Lucifer-yellow-filled cells, ultrastructural analysis of the postsynaptic density, and electrophysiological recordings of miniature EPSCs (mEPSCs) in mice after social defeat. We found that NAc MSNs have more stubby spine structures with smaller postsynaptic densities and an increase in the frequency of mEPSCs after social defeat. In parallel to these structural changes, we observed significant increases in IκB kinase (IKK) in the NAc after social defeat, a molecular pathway that has been shown to regulate neuronal morphology. Indeed, we find using viral-mediated gene transfer of dominant-negative and constitutively active IKK mutants that activation of IKK signaling pathways during social defeat is both necessary and sufficient to induce synaptic alterations and behavioral effects of the stress. These studies establish a causal role for IKK in regulating stress-induced adaptive plasticity and may present a novel target for drug development in the treatment of mood and anxiety disorders in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21209217      PMCID: PMC3219041          DOI: 10.1523/JNEUROSCI.4763-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

2.  Mechanisms of calcium decay kinetics in hippocampal spines: role of spine calcium pumps and calcium diffusion through the spine neck in biochemical compartmentalization.

Authors:  A Majewska; E Brown; J Ross; R Yuste
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

3.  CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli.

Authors:  Michel Barrot; Jocelien D A Olivier; Linda I Perrotti; Ralph J DiLeone; Olivier Berton; Amelia J Eisch; Soren Impey; Daniel R Storm; Rachael L Neve; Jerry C Yin; Venetia Zachariou; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-06       Impact factor: 11.205

4.  Synaptogenesis on mature hippocampal dendrites occurs via filopodia and immature spines during blocked synaptic transmission.

Authors:  Lara J Petrak; Kristen M Harris; Sergei A Kirov
Journal:  J Comp Neurol       Date:  2005-04-04       Impact factor: 3.215

Review 5.  The structural basis for mapping behavior onto the ventral striatum and its subdivisions.

Authors:  Gloria E Meredith; Brian A Baldo; Matthew E Andrezjewski; Ann E Kelley
Journal:  Brain Struct Funct       Date:  2008-02-07       Impact factor: 3.270

6.  DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses.

Authors:  Vincent Vialou; Alfred J Robison; Quincey C Laplant; Herbert E Covington; David M Dietz; Yoshinori N Ohnishi; Ezekiell Mouzon; Augustus J Rush; Emily L Watts; Deanna L Wallace; Sergio D Iñiguez; Yoko H Ohnishi; Michel A Steiner; Brandon L Warren; Vaishnav Krishnan; Carlos A Bolaños; Rachael L Neve; Subroto Ghose; Olivier Berton; Carol A Tamminga; Eric J Nestler
Journal:  Nat Neurosci       Date:  2010-05-16       Impact factor: 24.884

7.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

8.  Intense cocaine self-administration after episodic social defeat stress, but not after aggressive behavior: dissociation from corticosterone activation.

Authors:  Herbert E Covington; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2005-10-25       Impact factor: 4.530

9.  Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior.

Authors:  Ja Wook Koo; Scott J Russo; Deveroux Ferguson; Eric J Nestler; Ronald S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

10.  Axospinous synaptic subtype-specific differences in structure, size, ionotropic receptor expression, and connectivity in apical dendritic regions of rat hippocampal CA1 pyramidal neurons.

Authors:  Daniel A Nicholson; Yuri Geinisman
Journal:  J Comp Neurol       Date:  2009-01-20       Impact factor: 3.215

View more
  158 in total

1.  Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine.

Authors:  Yan Xia; George S Portugal; Amanda K Fakira; Zara Melyan; Rachael Neve; H Thomas Lee; Scott J Russo; Jie Liu; Jose A Morón
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.

Authors:  Ming-Hu Han; Allyson K Friedman
Journal:  Neuropharmacology       Date:  2011-09-17       Impact factor: 5.250

Review 3.  Structural and synaptic plasticity in stress-related disorders.

Authors:  Daniel J Christoffel; Sam A Golden; Scott J Russo
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

4.  Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice.

Authors:  Rachel D Penrod; Audrey M Wells; William A Carlezon; Christopher W Cowan
Journal:  Curr Protoc Neurosci       Date:  2015-10-01

5.  Genetic and Stress-Induced Loss of NG2 Glia Triggers Emergence of Depressive-like Behaviors through Reduced Secretion of FGF2.

Authors:  Fikri Birey; Michelle Kloc; Manideep Chavali; Israa Hussein; Michael Wilson; Daniel J Christoffel; Tony Chen; Michael A Frohman; John K Robinson; Scott J Russo; Arianna Maffei; Adan Aguirre
Journal:  Neuron       Date:  2015-11-20       Impact factor: 17.173

Review 6.  The molecular and cellular mechanisms of depression: a focus on reward circuitry.

Authors:  Megan E Fox; Mary Kay Lobo
Journal:  Mol Psychiatry       Date:  2019-04-09       Impact factor: 15.992

7.  Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior.

Authors:  Eric S Wohleb; Jenna M Patterson; Vikram Sharma; Ning Quan; Jonathan P Godbout; John F Sheridan
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

8.  Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain.

Authors:  Eric S Wohleb; Daniel B McKim; Daniel T Shea; Nicole D Powell; Andrew J Tarr; John F Sheridan; Jonathan P Godbout
Journal:  Biol Psychiatry       Date:  2013-12-10       Impact factor: 13.382

Review 9.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

10.  Selective Lesioning of Nuclear Factor-κB Activated Cells in the Nucleus Accumbens Shell Attenuates Alcohol Place Preference.

Authors:  S E Nennig; H D Fulenwider; S H Chimberoff; B M Smith; J E Eskew; M K Sequeira; C Karlsson; C Liang; J F Chen; M Heilig; J R Schank
Journal:  Neuropsychopharmacology       Date:  2017-09-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.